DOI: 10.1046/j.1365-2141.1998.00930.x. CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

10.1046/j.1365-2141.1998.00930.x

Crossref journal-article

Wiley

British Journal of Haematology (311)

Bibliography

BladÃ, J., Samson, D., Reece, D., Apperley, J., BJÃrkstrand, B., Gahrton, GÃ¶., Gertz, M., Giralt, S., Jagannath, Sundar., & Vesole, D. (1998). CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGHâDOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION. British Journal of Haematology, 102(5), 1115â1123. Portico.

Authors 11

Joan BladÉ (first)
Diana Samson (additional)
Donna Reece (additional)
Jane Apperley (additional)
Bo BJÖrkstrand (additional)
GÖsta Gahrton (additional)
Morie Gertz (additional)
Sergio Giralt (additional)
SUNDARr Jagannath (additional)
David Vesole (additional)
(additional)

References 39 Referenced 1,229

10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO;2-C
10.1182/blood.V82.8.2568.2568
10.1056/NEJM199607113350204
10.1002/1097-0142(19910701)68:1<62::AID-CNCR2820680112>3.0.CO;2-6
10.1046/j.1365-2141.1997.d01-2083.x
10.1182/blood.V89.3.789
10.1038/bjc.1988.17
Bergsagel D.E.(1975) Plasma cell myeloma: prognostic factors and criteria of response to therapy.Cancer Therapy: Prognostic Factors and Criteria of Response(ed. by M. J. Staquet) pp.7387. Raven Press New York.
Bergsagel D.E.(1998) Chemotherapy of myeloma.Multiple Myeloma: Biology and Management(ed. by J. S. Malpas D. E. Bergsagel R. A. Kyle and K. C. Anderson) pp.269302. Oxford University Press.
10.1056/NEJM197910043011402
{'key': 'e_1_2_7_12_2', 'first-page': '651', 'article-title': 'Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence of cure in long‐term survivors', 'volume': '12', 'author': 'Bird J.M.', 'year': '1993', 'journal-title': 'Bone Marrow Transplantation'} / Bone Marrow Transplantation / Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence of cure in long‐term survivors by Bird J.M. (1993)
{'issue': '2', 'key': 'e_1_2_7_13_2', 'first-page': '140', 'article-title': 'Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation', 'volume': '13', 'author': 'Bjorkstrand B.', 'year': '1995', 'journal-title': 'Stem Cells, Daytona'} / Stem Cells, Daytona / Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation by Bjorkstrand B. (1995)
{'key': 'e_1_2_7_14_2', 'first-page': '367', 'article-title': 'Double high‐dose therapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma', 'volume': '15', 'author': 'Bjorkstrand B.', 'year': '1995', 'journal-title': 'Bone Marrow Transplantation'} / Bone Marrow Transplantation / Double high‐dose therapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma by Bjorkstrand B. (1995)
10.1111/j.1365-2141.1994.tb04986.x
10.1016/0277-5379(86)90320-2
{'key': 'e_1_2_7_17_2', 'first-page': '145', 'article-title': 'Proposed guidelines for protocol studies. II. Plasma cell myeloma', 'volume': '4', 'year': '1973', 'journal-title': 'Cancer Chemotherapy Reports'} / Cancer Chemotherapy Reports / Proposed guidelines for protocol studies. II. Plasma cell myeloma (1973)
{'key': 'e_1_2_7_18_2', 'first-page': '17', 'article-title': 'Proposed guidelines for protocol studies. II. Plasma cell myeloma', 'volume': '1', 'author': 'Chronic Leukemia and Myeloma Task Force', 'year': '1968', 'journal-title': 'Cancer Chemotherapy Reports'} / Cancer Chemotherapy Reports / Proposed guidelines for protocol studies. II. Plasma cell myeloma by Chronic Leukemia and Myeloma Task Force (1968)
10.1182/blood.V82.6.1929.1929 / Blood / Competitive polymerase chain reaction to estimate the number of bcr‐abl transcripts in chronic myeloid leukemia after bone marrow transplantation by Cross N.C.P. (1993)
10.1182/blood.V82.8.2324.bloodjournal8282324 / Blood / Thiotepa, busulfan and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high‐risk multiple myeloma by Dimopoulos M.A. (1993)
10.1016/S0140-6736(80)92941-4
10.1056/NEJM199110313251802
10.1200/JCO.1995.13.6.1312
10.1016/S0140-6736(89)91548-1
10.1182/blood.V27.3.328.328
10.1046/j.1365-2141.1997.9942643.x
{'key': 'e_1_2_7_27_2', 'first-page': '59', 'article-title': 'Multiple myeloma: plateau phase revisited', 'volume': '5', 'author': 'Joshua D.E.', 'year': '1991', 'journal-title': 'Hematology Reviews'} / Hematology Reviews / Multiple myeloma: plateau phase revisited by Joshua D.E. (1991)
10.1001/jama.1964.03070100052010
10.1056/NEJM198006123022405
10.1016/0140-6736(92)90004-M
10.1136/bmj.308.6935.1033
Malpas J.S.(1998) Clinical presentation and diagnosis.Myeloma: Biology and Management(ed. by J. S. Malpas D. E. Bergsagel R. A. Kyle and K. C. Anderson) pp.187209. Oxford University Press.
10.1093/oxfordjournals.annonc.a057902
10.1182/blood.V60.4.851.851 / Blood / Myeloma protein kinetics following chemotherapy by McLaughlin P. (1982)
10.1046/j.1365-2141.1996.413952.x
10.1038/bjc.1989.22
10.1016/S0140-6736(89)91549-3
10.1038/sj.bmt.1701055
10.1111/j.1365-2141.1987.tb06890.x
10.1182/blood.V88.3.838.838 / Blood / Autotransplants in myeloma: what have we learned? by Vesole D.H. (1996)

Dates

Type	When
Created	22 years, 5 months ago (March 11, 2003, 1:04 a.m.)
Deposited	1 year, 10 months ago (Oct. 27, 2023, 7:01 p.m.)
Indexed	1 month, 2 weeks ago (July 11, 2025, 6:20 a.m.)
Issued	26 years, 11 months ago (Sept. 1, 1998)
Published	26 years, 11 months ago (Sept. 1, 1998)
Published Online	16 years, 10 months ago (Oct. 9, 2008)
Published Print	26 years, 11 months ago (Sept. 1, 1998)

Funders 0

None

BibTeX

@article{Blad__1998, title={CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION}, volume={102}, ISSN={1365-2141}, url={http://dx.doi.org/10.1046/j.1365-2141.1998.00930.x}, DOI={10.1046/j.1365-2141.1998.00930.x}, number={5}, journal={British Journal of Haematology}, publisher={Wiley}, author={BladÉ, Joan and Samson, Diana and Reece, Donna and Apperley, Jane and BJÖrkstrand, Bo and Gahrton, GÖsta and Gertz, Morie and Giralt, Sergio and Jagannath, SUNDARr and Vesole, David}, year={1998}, month=sep, pages={1115–1123} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        11
      ]
    ],
    "date-time": "2025-07-11T10:20:59Z",
    "timestamp": 1752229259083
  },
  "reference-count": 39,
  "publisher": "Wiley",
  "issue": "5",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2008,
            10,
            9
          ]
        ],
        "date-time": "2008-10-09T00:00:00Z",
        "timestamp": 1223510400000
      },
      "content-version": "vor",
      "delay-in-days": 3691,
      "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor"
    }
  ],
  "content-domain": {
    "domain": [
      "onlinelibrary.wiley.com"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  },
  "DOI": "10.1046/j.1365-2141.1998.00930.x",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2003,
        3,
        11
      ]
    ],
    "date-time": "2003-03-11T06:04:35Z",
    "timestamp": 1047362675000
  },
  "page": "1115-1123",
  "update-policy": "http://dx.doi.org/10.1002/crossmark_policy",
  "source": "Crossref",
  "is-referenced-by-count": 1229,
  "title": "CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH\u2010DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION",
  "prefix": "10.1111",
  "volume": "102",
  "author": [
    {
      "given": "Joan",
      "family": "Blad\u00c9",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Diana",
      "family": "Samson",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Donna",
      "family": "Reece",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Jane",
      "family": "Apperley",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Bo",
      "family": "BJ\u00d6rkstrand",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "G\u00d6sta",
      "family": "Gahrton",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Morie",
      "family": "Gertz",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Sergio",
      "family": "Giralt",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "SUNDARr",
      "family": "Jagannath",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "David",
      "family": "Vesole",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "name": "On behalf of the Myeloma, Subcommittee of the EBMT, (European Group for Blood, and Marrow Transplant), Chronic Leukaemia Working, Party and the Myeloma, Working Committee of the, IBMTR (International Bone, Marrow Transplant Registry), and ABMTR (Autologous Blood, and Marrow Transplant Registry)",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "311",
  "published-online": {
    "date-parts": [
      [
        2008,
        10,
        9
      ]
    ]
  },
  "reference": [
    {
      "key": "e_1_2_7_2_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO;2-C"
    },
    {
      "key": "e_1_2_7_3_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1182/blood.V82.8.2568.2568"
    },
    {
      "key": "e_1_2_7_4_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1056/NEJM199607113350204"
    },
    {
      "key": "e_1_2_7_5_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1002/1097-0142(19910701)68:1<62::AID-CNCR2820680112>3.0.CO;2-6"
    },
    {
      "key": "e_1_2_7_6_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1046/j.1365-2141.1997.d01-2083.x"
    },
    {
      "key": "e_1_2_7_7_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1182/blood.V89.3.789"
    },
    {
      "key": "e_1_2_7_8_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1038/bjc.1988.17"
    },
    {
      "key": "e_1_2_7_9_2",
      "unstructured": "Bergsagel D.E.(1975) Plasma cell myeloma: prognostic factors and criteria of response to therapy.Cancer Therapy: Prognostic Factors and Criteria of Response(ed. by M. J. Staquet) pp.7387. Raven Press New York."
    },
    {
      "key": "e_1_2_7_10_2",
      "unstructured": "Bergsagel D.E.(1998) Chemotherapy of myeloma.Multiple Myeloma: Biology and Management(ed. by J. S. Malpas D. E. Bergsagel R. A. Kyle and K. C. Anderson) pp.269302. Oxford University Press."
    },
    {
      "key": "e_1_2_7_11_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1056/NEJM197910043011402"
    },
    {
      "key": "e_1_2_7_12_2",
      "first-page": "651",
      "article-title": "Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence of cure in long\u2010term survivors",
      "volume": "12",
      "author": "Bird J.M.",
      "year": "1993",
      "journal-title": "Bone Marrow Transplantation"
    },
    {
      "issue": "2",
      "key": "e_1_2_7_13_2",
      "first-page": "140",
      "article-title": "Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation",
      "volume": "13",
      "author": "Bjorkstrand B.",
      "year": "1995",
      "journal-title": "Stem Cells, Daytona"
    },
    {
      "key": "e_1_2_7_14_2",
      "first-page": "367",
      "article-title": "Double high\u2010dose therapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma",
      "volume": "15",
      "author": "Bjorkstrand B.",
      "year": "1995",
      "journal-title": "Bone Marrow Transplantation"
    },
    {
      "key": "e_1_2_7_15_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1111/j.1365-2141.1994.tb04986.x"
    },
    {
      "key": "e_1_2_7_16_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/0277-5379(86)90320-2"
    },
    {
      "key": "e_1_2_7_17_2",
      "first-page": "145",
      "article-title": "Proposed guidelines for protocol studies. II. Plasma cell myeloma",
      "volume": "4",
      "year": "1973",
      "journal-title": "Cancer Chemotherapy Reports"
    },
    {
      "key": "e_1_2_7_18_2",
      "first-page": "17",
      "article-title": "Proposed guidelines for protocol studies. II. Plasma cell myeloma",
      "volume": "1",
      "author": "Chronic Leukemia and Myeloma Task Force",
      "year": "1968",
      "journal-title": "Cancer Chemotherapy Reports"
    },
    {
      "key": "e_1_2_7_19_2",
      "doi-asserted-by": "crossref",
      "first-page": "1929",
      "DOI": "10.1182/blood.V82.6.1929.1929",
      "article-title": "Competitive polymerase chain reaction to estimate the number of bcr\u2010abl transcripts in chronic myeloid leukemia after bone marrow transplantation",
      "volume": "82",
      "author": "Cross N.C.P.",
      "year": "1993",
      "journal-title": "Blood"
    },
    {
      "key": "e_1_2_7_20_2",
      "doi-asserted-by": "crossref",
      "first-page": "2324",
      "DOI": "10.1182/blood.V82.8.2324.bloodjournal8282324",
      "article-title": "Thiotepa, busulfan and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high\u2010risk multiple myeloma",
      "volume": "82",
      "author": "Dimopoulos M.A.",
      "year": "1993",
      "journal-title": "Blood"
    },
    {
      "key": "e_1_2_7_21_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0140-6736(80)92941-4"
    },
    {
      "key": "e_1_2_7_22_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1056/NEJM199110313251802"
    },
    {
      "key": "e_1_2_7_23_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1200/JCO.1995.13.6.1312"
    },
    {
      "key": "e_1_2_7_24_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0140-6736(89)91548-1"
    },
    {
      "key": "e_1_2_7_25_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1182/blood.V27.3.328.328"
    },
    {
      "key": "e_1_2_7_26_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1046/j.1365-2141.1997.9942643.x"
    },
    {
      "key": "e_1_2_7_27_2",
      "first-page": "59",
      "article-title": "Multiple myeloma: plateau phase revisited",
      "volume": "5",
      "author": "Joshua D.E.",
      "year": "1991",
      "journal-title": "Hematology Reviews"
    },
    {
      "key": "e_1_2_7_28_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1001/jama.1964.03070100052010"
    },
    {
      "key": "e_1_2_7_29_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1056/NEJM198006123022405"
    },
    {
      "key": "e_1_2_7_30_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/0140-6736(92)90004-M"
    },
    {
      "key": "e_1_2_7_31_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1136/bmj.308.6935.1033"
    },
    {
      "key": "e_1_2_7_32_2",
      "unstructured": "Malpas J.S.(1998) Clinical presentation and diagnosis.Myeloma: Biology and Management(ed. by J. S. Malpas D. E. Bergsagel R. A. Kyle and K. C. Anderson) pp.187209. Oxford University Press."
    },
    {
      "key": "e_1_2_7_33_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1093/oxfordjournals.annonc.a057902"
    },
    {
      "key": "e_1_2_7_34_2",
      "doi-asserted-by": "crossref",
      "first-page": "851",
      "DOI": "10.1182/blood.V60.4.851.851",
      "article-title": "Myeloma protein kinetics following chemotherapy",
      "volume": "60",
      "author": "McLaughlin P.",
      "year": "1982",
      "journal-title": "Blood"
    },
    {
      "key": "e_1_2_7_35_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1046/j.1365-2141.1996.413952.x"
    },
    {
      "key": "e_1_2_7_36_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1038/bjc.1989.22"
    },
    {
      "key": "e_1_2_7_37_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1016/S0140-6736(89)91549-3"
    },
    {
      "key": "e_1_2_7_38_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1038/sj.bmt.1701055"
    },
    {
      "key": "e_1_2_7_39_2",
      "doi-asserted-by": "publisher",
      "DOI": "10.1111/j.1365-2141.1987.tb06890.x"
    },
    {
      "key": "e_1_2_7_40_2",
      "doi-asserted-by": "crossref",
      "first-page": "838",
      "DOI": "10.1182/blood.V88.3.838.838",
      "article-title": "Autotransplants in myeloma: what have we learned?",
      "volume": "88",
      "author": "Vesole D.H.",
      "year": "1996",
      "journal-title": "Blood"
    }
  ],
  "container-title": "British Journal of Haematology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.1998.00930.x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.1998.00930.x",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.1998.00930.x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        10,
        27
      ]
    ],
    "date-time": "2023-10-27T23:01:23Z",
    "timestamp": 1698447683000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.1998.00930.x"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  },
  "references-count": 39,
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          1998,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "10.1046/j.1365-2141.1998.00930.x"
  ],
  "URL": "http://dx.doi.org/10.1046/j.1365-2141.1998.00930.x",
  "relation": {},
  "ISSN": [
    "0007-1048",
    "1365-2141"
  ],
  "subject": [],
  "container-title-short": "Br J Haematol",
  "published": {
    "date-parts": [
      [
        1998,
        9
      ]
    ]
  },
  "assertion": [
    {
      "value": "2008-10-09",
      "order": 2,
      "name": "published",
      "label": "Published",
      "group": {
        "name": "publication_history",
        "label": "Publication History"
      }
    }
  ]
}